Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010

British Journal of Cancer

Volumn 105, Issue , 2011, Pages S66-S69

  Parkin, D M ^a   Mesher, D ^a   Sasieni, P ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; HUMAN; MALE; MELANOMA; MIDDLE AGED; RADIATION INDUCED NEOPLASM; SKIN TUMOR; SUNLIGHT; ULTRAVIOLET RADIATION; UNITED KINGDOM; PRIORITY JOURNAL; RADIATION EXPOSURE; SKIN CANCER; SOLAR RADIATION;

ADULT; FEMALE; GREAT BRITAIN; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; SKIN NEOPLASMS; SUNLIGHT; ULTRAVIOLET RAYS;

EID: 83255175647     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.486     Document Type: Article

References (15)

1. Armstrong BK, Kricker A (1993) How much melanoma is caused by sun exposure? Melanoma Res 3: 395–401
2. Dennis LK (1999) Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. Arch Dermatol 135: 275–280
3. de Vries E, Bray FI, Coebergh JW, Parkin DM (2003) Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia. Int J Cancer 107: 119–126
4. de Vries E, Coebergh JW (2004) Cutaneous malignant melanoma in Europe. Eur J Cancer 40: 2355–2366
5. de Vries E, Coebergh JW (2005) Melanoma incidence has risen in Europe. Br Med J 331: 698
6. El Ghissassi F, Baan R, Straif K, Grosse Y, Secretan B, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V (2009) WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens–part D: radiation. Lancet Oncol 10: 751–752
7. Green A, MacLennan R, Youl P, Martin N (1993) Site distribution of cutaneous melanoma in Queensland. Int J Cancer 53: 232–236
8. IARC (1992) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 55. Solar and Ultraviolet Radiation. IARC: Lyon
9. IARC (2007) Attributable causes of cancer in France in the year 2000. IARC Working Group Reports 3.
10. Lens MB, Dawes M (2004) Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 150: 179–185
11. Lipsker DM, Hedelin G, Heid E, Grosshans EM, Cribier BJ (1999) Striking increase of thin melanomas contrasts with stable incidence of thick melanomas. Arch Dermatol 135: 1451–1456
12. MacKie RM, Bray CA, Hole DJ, Morris A, Nicolson M, Evans A, Doherty V, Vestey J, Scottish Melanoma Group (2002) Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet 360: 587–591
13. Parkin DM, Whelan S, Ferlay J, Storm H (2005) Cancer Incidence in Five Continents, Vol. I to VIII. IARC Cancer Base No. 7: Lyon
14. van der Esch EP, Muir CS, Nectux J, Macfarlane G, Maisonneuve P, Bharucha H, Briggs J, Cooke RA, Dempster AG, Essex WB, Hofer PA, Hood AF, Ironside P, Larsen TE, Little H, Philipps R, Pfau RS, Prade M, Pozharisski KM, Rilke F, Schafler K (1991) Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 47: 483–489
15. Winther JF, Ulbak K, Dreyer L, Pukkala E, Osterlind A(1997) Avoidable cancers in the Nordic countries. Radiation. APMIS Suppl 76: 83–99